These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 19463751)

  • 1. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Pachuta A; Bochenski M; Silberring J
    Peptides; 2009 Jun; 30(6):1165-72. PubMed ID: 19463751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats.
    Kotlinska JH; Gibula-Bruzda E; Koltunowska D; Raoof H; Suder P; Silberring J
    Peptides; 2012 Jan; 33(1):156-63. PubMed ID: 22197492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats.
    Kotlinska J; Pachuta A; Dylag T; Silberring J
    Peptides; 2007 Nov; 28(11):2235-42. PubMed ID: 17884254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
    Valdez GR; Roberts AJ; Chan K; Davis H; Brennan M; Zorrilla EP; Koob GF
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of alpha-melanocyte stimulating hormone in ethanol-induced anxiolysis and withdrawal anxiety in rats.
    Kokare DM; Chopde CT; Subhedar NK
    Neuropharmacology; 2006 Sep; 51(3):536-45. PubMed ID: 16762375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats.
    Taksande BG; Kotagale NR; Patel MR; Shelkar GP; Ugale RR; Chopde CT
    Eur J Pharmacol; 2010 Jul; 637(1-3):89-101. PubMed ID: 20394743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enkephalin analog, cyclo[N(ε),N(β)-carbonyl-D-Lys(2),Dap(5)] enkephalinamide (cUENK6), inhibits the ethanol withdrawal-induced anxiety-like behavior in rats.
    Gibula-Bruzda E; Marszalek-Grabska M; Witkowska E; Izdebski J; Kotlinska JH
    Alcohol; 2015 May; 49(3):229-36. PubMed ID: 25716198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Bochenski M
    Eur J Pharmacol; 2008 Nov; 598(1-3):57-63. PubMed ID: 18838071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent rats.
    Zhao Y; Weiss F; Zorrilla EP
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1505-15. PubMed ID: 17760785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of neuropeptide FF (NPFF) in the expression of sensitization to hyperlocomotor effect of morphine and ethanol.
    Kotlinska J; Pachuta A; Dylag T; Silberring J
    Neuropeptides; 2007 Feb; 41(1):51-8. PubMed ID: 17107711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased elevated plus maze open-arm time in mice during spontaneous morphine withdrawal.
    Buckman SG; Hodgson SR; Hofford RS; Eitan S
    Behav Brain Res; 2009 Feb; 197(2):454-6. PubMed ID: 18955087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The consequences of beer consumption in rats: acute anxiolytic and ataxic effects and withdrawal-induced anxiety.
    Gallate JE; Morley KC; Ambermoon P; McGregor IS
    Psychopharmacology (Berl); 2003 Feb; 166(1):51-60. PubMed ID: 12474111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
    Hodgson SR; Hofford RS; Norris CJ; Eitan S
    Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo studies of dansylated compounds, the putative agonists and antagonists on neuropeptide FF receptors.
    Fang Q; Guo J; Peng YL; Chang M; He F; Chen Q; Wang R
    Peptides; 2006 Jun; 27(6):1297-304. PubMed ID: 16337714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of the gene transcription factor cyclic AMP-responsive element binding protein in ethanol withdrawal-related anxiety.
    Pandey SC; Zhang D; Mittal N; Nayyar D
    J Pharmacol Exp Ther; 1999 Feb; 288(2):866-78. PubMed ID: 9918601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the use-dependent, nicotinic receptor antagonist BTMPS in the forced swim test and elevated plus maze after cocaine discontinuation in rats.
    Hall BJ; Pearson LS; Buccafusco JJ
    Neurosci Lett; 2010 Apr; 474(2):84-7. PubMed ID: 20226229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system.
    Zarrindast MR; Sarahroodi S; Arzi A; Khodayar MJ; Taheri-Shalmani S; Rezayof A
    Behav Pharmacol; 2008 Oct; 19(7):716-23. PubMed ID: 18797248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mianserin in the treatment of ethanol withdrawal in the rat: prevention of behaviors indicative of anxiety.
    Prather PL; Rezazadeh SM; Lal H
    Psychopharmacol Bull; 1991; 27(3):285-9. PubMed ID: 1775600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety-like behaviors following chronic ethanol exposure.
    Kliethermes CL
    Neurosci Biobehav Rev; 2005 Jan; 28(8):837-50. PubMed ID: 15642625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of centrally-injected glucagon-like peptide-1 on pilocarpine-induced seizures, anxiety and locomotor and exploratory activity in rat.
    Gulec G; Isbil-Buyukcoskun N; Kahveci N
    Neuropeptides; 2010 Aug; 44(4):285-91. PubMed ID: 20227110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.